Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Guben Kechuan Granules for AECOPD During Peri-Discharge Period
NCT07456813Not yet recruiting
- Start
- Mar 2026
- Primary completion
- Dec 2027
- Modality
- Small Molecules
01
Overview
Randomised trial of Guben Kechuan in chronic obstructive pulmonary disease (COPD) (2 arms). Primary endpoint: Forced Expiratory Volume in 1 second at 12 weeks. Planned start Mar 2026; status: not yet recruiting.
02
Drugs
Guben Kechuan
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT07456813.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07456813.